
BioTech Nation ... with Dr. Moira Gunn
Moira GunnAudio
- Format:
- Podcast
- New episodes:
- Weekly
- Typical length:
- about 20 minutes
- Latest episode:
About this show
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for everyone. These interviews are drawn directly from the public radio program, "Tech Nation", which also can be heard in numerous global radio and podcasting venues.
Covers: biotechnology, drug development, pharmaceutical industry, entrepreneurship, cancer treatment, artificial intelligence, chemistry, gout treatment
Show details and episodes come from the publisher's public feed at feeds.transistor.fm. Last updated . Names, artwork and text belong to their publishers.
Recently on this show
Summary of recent episodes, drawn from the publisher's feed.
BioTech Nation is an interview podcast, hosted by Moira Gunn, that explains science and biotech topics without requiring a science background. Recent episodes cover chemistry in everyday life, engineering microbes as fertilizer alternatives, and an early intervention treatment for heart attacks.
Cosmos
Similar in subject
- Chemistry World Podcast
Both cover: cancer treatment, chemistry - Approved
Both cover: drug development, biotechnology - BiotechTV - News
Both cover: pharmaceutical industry, biotechnology
Similar shows
Explore more
Episodes
You’ve Had Back Pain for 7-10 Years? Neil Klompas, CEO, Augurex
· 8 min
This is the 2026 BioTech Nation "5" (https://www.biotechnation.com/jpm-2026-btn-5): Five Companies Ready to Make a Difference. We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco. Hear all 5 interviews at https://www.biotechnation.com/jpm-2026-btn-5 On this episode of BioTech Nation...Moira speaks with Neil Klompas of Augurex Life Sciences, about a new diagnostic for chronic, long-term back pain that pinpoints a form of arthritis. On average, patients with this condition could go 7-10 years without a diagnosis, having to first eliminate everything else with an odyssey of tests. Now, a simple blood test could be the answer. For more information about BioTech Nation and the companies featured here, visit: TechNation.com (https://technation.com/)
Not rated yetA Fast-Acting Dupixent? Dr. Barry Quart, CEO, Connect Biopharma
· 10 min
This is the 2026 BioTech Nation "5" (https://www.biotechnation.com/jpm-2026-btn-5): Five Companies Ready to Make a Difference. We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco. Hear all 5 interviews at https://www.biotechnation.com/jpm-2026-btn-5 On this episode of BioTech Nation, Moira speaks with Dr. Barry Quart, CEO of Connect Biopharma, about a new fast-acting treatment for inflammatory conditions like Asthma, COPD, and Eczema. Often, these conditions can be managed with anti-inflammatory therapeutics like Dupixent, but even then, sudden and painful flare-ups can occur. We take a closer look at a new anti-inflammatory in late-stage development which starts working quickly, much needed when those flare-ups develop. For more information about BioTech Nation and the companies featured here, visit: TechNation.com (https://technation.com/)
Not rated yetA Speedy Intervention for Heart Attacks, Dr. Harry Selker & Dr. Atul Deshpande, Immediate Therapeutics
· 20 min
This is the 2026 BioTech Nation "5" (https://www.biotechnation.com/jpm-2026-btn-5): Five Companies Ready to Make a Difference. We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco. Hear all 5 interviews at https://www.biotechnation.com/jpm-2026-btn-5 On this episode of BioTech Nation... Dr. Harry Selker & Dr. Atul Deshpande of Immediate Therapeutics speak with Moira about a new treatment that could be administered to heart attack patients right away...potentially before they even arrive at the hospital. Already successfully tested in Phase 2, it’s ready to go into final pivotal trials in Ambulances and Emergency Rooms. For more information about BioTech Nation and the companies featured here, visit: TechNation.com (https://technation.com/)
Not rated yetA New Way to Treat Cancer, Cyriac Roeding & Dr. David Suhy, Co-Founders, Earli
· 23 min
This is the 2026 BioTech Nation "5" (https://www.biotechnation.com/jpm-2026-btn-5): Five Companies Ready to Make a Difference. We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco. Hear all 5 interviews at https://www.biotechnation.com/jpm-2026-btn-5 On this episode of BioTech Nation: Can cancer cells be turned against themselves? Moira speaks with Cyriac Roeding and Dr. David Suhy, Co-Founders of Earli, about an innovative new approach to treating solid tumor cancer. They discuss their effort to turn the cancer cells inside solid tumors into factories that produce their own cancer-fighting therapeutic. For more information about BioTech Nation and the companies featured here, visit: TechNation.com (https://technation.com/)
Not rated yetDecoding Diseases of Aging...Dr. Martin Borch Jensen and Dr. Francisco LePort, Gordian Biotechnology
· 25 min
This week on Biotech Nation, Dr. Martin Borch Jensen and Dr. Francisco LePort from Gordian Biotechnology share a bold new approach to fighting diseases of aging before they take hold. Instead of testing one drug at a time, their technology allows scientists to test hundreds of potential treatments at once, making drug discovery faster and more precise. This could change how we treat conditions like arthritis, heart failure, and fatty liver disease.
Not rated yetWhen Your Immune System Overreacts...Prof. Dr. Niels Riedemann, Co-Founder & CEO, InflaRx
· 21 min
This week on BioTech Nation, we explore what happens when your immune system overreacts. Professor Niels Riedemann, CEO of InflaRx, explains how the body’s defense system can sometimes cause more harm than good, leading to serious conditions like rheumatoid arthritis, severe COVID-19, and lung failure. Learn how InflaRx is developing treatments to calm the immune system and why their breakthrough drug is getting attention from U.S. health agencies.
Not rated yetRenewed Potential: Reviving an ALS Drug...Dr. Ari Azhir, Founder & CEO, Neuvivo
· 17 min
This week on Biotech Nation, Dr. Ari Azhir, Founder and CEO of Neuvivo, shares the incredible journey of an ALS drug that was once abandoned, but is now making its way toward FDA approval. After two failed phase two trials, the drug was left behind until Dr. Azhir and her team discovered a crucial mistake in the trial data. Now with new insights and groundbreaking survival results, Neuvivo is giving hope to ALS patients and exploring its potential for other neurodegenerative diseases like Huntington’s and Alzheimer’s.
Not rated yetPreventing Pressure Injuries: Detecting the Invisible Signs, Martin Burns, CEO Bruin Biometrics
· 19 min
This week on BioTech Nation, Bruin Biometrics CEO Martin Burns talks about a new diagnostic tool being used to detect and prevent potentially fatal bedsores in their earliest stages.
Not rated yetAre we moving from Dr. Google to Dr. ChatGPT??? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
· 6 min
For years, we've all turned to Google to self-diagnose every cough, rash, and weird pain. Dr. Daniel Kraft says the shift is happening, from Dr. Google to Dr. ChatGPT.
Not rated yetConnecting the Data that Changes Medicine, Dr. Lincoln Nadauld, President & CEO, Culmination Bio
· 17 min
This week on Biotech Nation, Dr. Lincoln Nadauld shares how Culmination Bio is using 9 million preserved tissue samples and decades of patient data to improve how we understand and treat diseases. From discovering patterns in cancer treatments to exploring breakthroughs in heart and autoimmune diseases, this unique approach is changing medicine.
Not rated yet